Shopping Cart 0
Cart Subtotal
USD 0

Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin, and Other Tests) By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Clinical Chemistry Technologies, and Others) for End-use Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4199

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6299

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 8399
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

The report covers forecast and analysis for the endocrine testing market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the endocrine testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the endocrine testing market on a global level. This report offers comprehensive coverage on global endocrine testing market along with, market trends, drivers and restraints of endocrine testing market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the endocrine testing market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts. The study provides a decisive view on the endocrine testing market by segmenting the market based on test, technology, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The test market covered under this study includes Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Some of the key technologies in the market include monoclonal polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. The end-users segmentation includes commercial laboratories, home-based tests, ambulatory care centers, hospitals and other. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global endocrine testing market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA. This report segments the global endocrine testing market as follows: Global Endocrine Testing Market: Tests Segment Analysis Dehydroepiandrosterone sulfate (DHEAS) Progesterone Luteinizing Hormone (LH) Estradiol (E2) Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH) Testosterone Thyroid prolactin Thyroid Stimulating Hormone (TSH), cortisol, insulin Other Test Global Endocrine Testing Market: Technology Segment Analysis Monoclonal Polyclonal Antibody Technologies Tandem Mass Spectrometry Immunoassay Sensors Clinical Chemistry Technologies Others Global Endocrine Testing Market: End-user Segment Analysis Commercial Laboratories Home-Based Tests Ambulatory Care Centers Hospitals Other Healthcare Settings Global Endocrine Testing Market: Regional Segment Analysis North America Europe Asia Pacific Latin America Middle East and Africa

READ MORE

Table Of Content

Scope

Chapter 1. Introduction 1.1. Report Description And Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter 2. Executive Summary 2.1. Global Endocrine Testing Market, 2015-2021 (USD Million) 2.2. Global Endocrine Testing Market: Snapshot Chapter 3. Endocrine Testing Market Dynamics 3.1. Introduction 3.2. Market Drivers 3.2.1. Global Endocrine testing Market Drivers: Impact Analysis 3.2.2. Rising Diabetic and Obese Population 3.3. Market Restraints 3.3.1. Global Endocrine testing Market Restraints: Impact Analysis 3.3.2. High Cost of Technology 3.4. Opportunities 3.4.1. Innovative Products 3.5. Porters Five Forces Analysis 3.5.1. Bargaining Power Of Suppliers 3.5.2. Bargaining Power Of Buyers 3.5.3. Threat From New Entrants 3.5.4. Threat From New Substitutes 3.5.5. Degree Of Competition 3.6. Market Attractiveness Analysis 3.6.1. Market Attractiveness Analysis, By Test Segment 3.6.2. Market Attractiveness Analysis, By Technology Segment 3.6.3. Market Attractiveness Analysis, By End-User Segment 3.6.4. Market Attractiveness Analysis, By Regional Segment Chapter 4. Global Endocrine Testing Market Competitive Landscape 4.1. Company Market Share, 2015 (Subject To Data Availability) 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Type Launch 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures 4.2.4. Research And Development, Regional Expansion 4.3. Type Portfolio Chapter 5. Global Endocrine Testing Market Test Analysis 5.1. Global Endocrine Testing Market: Test Segment Overview 5.1.1. Global Endocrine Testing Market Revenue Share, By Test, 2015 And 2021 5.2. Dehydroepiandrosterone Sulfate 5.2.1. Global Endocrine Testing Market for Dehydroepiandrosterone Sulfate, 2015 2021 (USD Million) 5.3. Progesterone 5.3.1. Global Endocrine Testing Market for Progesterone, 2015 2021 (USD Million) 5.4. Luteinizing Hormone 5.4.1. Global Endocrine Testing Market For Luteinizing Hormone, 2015 2021 (USD Million) 5.5. Estradiol 5.5.1. Global Endocrine Testing Market for Estradiol, 2015 2021 (USD Million) 5.6. Human Chorionic Gonadotropin 5.6.1. Global Endocrine Testing Market for Human Chorionic Gonadotropin, 2015 2021 (USD Million) 5.7. Follicle Stimulating 5.7.1. Global Endocrine Testing Market for Follicle Stimulating, 2015 2021 (USD Million) 5.8. Testosterone 5.8.1. Global Endocrine Testing Market for Testosterone, 2015 2021 (USD Million) 5.9. Thyroid Prolactin 5.9.1. Global Endocrine Testing Market for Thyroid Prolactin, 2015 2021 (USD Million) 5.10. Thyroid Stimulating Hormone 5.10.1. Global Endocrine Testing Market for Thyroid Stimulating Hormone, 2015 2021 (USD Million) 5.11. Cortisol 5.11.1. Global Endocrine Testing Market for Cortisol, 2015 2021 (USD Million) 5.12. Insulin 5.12.1. Global Endocrine Testing Market for Insulin, 2015 2021 (USD Million) 5.13. Others 5.13.1. Global Endocrine Testing Market for Other Test, 2015 2021 (USD Million) Chapter 6. Global Endocrine Testing Market Technology Segment Analysis 6.1. Global Endocrine testing Market: Technology Segment Overview 6.1.1. Global Endocrine testing Market Revenue Share, By Technology, 2015 And 2021 6.2. Monoclonal Polyclonal Antibody Technologies 6.2.1. Global Endocrine Testing Market For Monoclonal Polyclonal Antibody Technologies, 2015 2021 (USD Million) 6.3. Tandem Mass Spectrometry 6.3.1. Global Endocrine Testing Market For Tandem Mass Spectrometry, 2015 2021 (USD Million) 6.4. Immunoassay 6.4.1. Global Endocrine Testing Market for Immunoassay, 2015 2021 (USD Million) 6.5. Clinical Chemistry Technologies 6.5.1. Global Endocrine Testing Market for Clinical Chemistry Technologies, 2015 2021 (USD Million) 6.6. Other 6.6.1. Global Endocrine Testing Market for Other Technologies, 2015 2021 (USD Million) Chapter 7. Global Endocrine Testing Market End-User Segment Analysis 7.1. Global Endocrine testing Market: End-User Segment Overview 7.1.1. Global Endocrine testing Market Revenue Share, By End-User, 2015 And 2021 7.2. Commercial Laboratories 7.2.1. Global Endocrine Testing Market For Commercial Laboratories, 2015 2021 (USD Million) 7.3. Home-Based Tests 7.3.1. Global Endocrine Testing Market for Home-Based Tests 2015 2021 (USD Million) 7.4. Ambulatory Care Centers 7.4.1. Global Endocrine Testing Market for Ambulatory Care Centers 2015 2021 (USD Million) 7.5. Hospitals 7.5.1. Global Endocrine Testing Market for Hospitals 2015 2021 (USD Million) 7.6. Other 7.6.1. Global Endocrine Testing Market for other, 2015 2021 (USD Million) Chapter 8. Global Endocrine Testing Market Regional Segment Analysis 8.1. Global Endocrine Testing Market: Regional Overview 8.1.1. Global Endocrine Testing Market Revenue Share, By Region, 2015 And 2021 8.2. North America 8.2.1. North America Endocrine Testing Market Revenue, By Test, 2015 2021 , (Usd Million) 8.2.2. North America Endocrine Testing Market Revenue, By Technology, 2015 2021 , (USD Million) 8.2.3. North America Endocrine Testing Market Revenue, By End-User Type, 2015 2021 , (USD Million) 8.3. Europe 8.3.1. Europe Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million) 8.3.2. Europe Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million) 8.3.3. Europe Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million) 8.4. Asia Pacific 8.4.1. Asia Pacific Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million) 8.4.2. Asia Pacific Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million) 8.4.3. Asia Pacific Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million) 8.5. Latin America 8.5.1. Latin America Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million) 8.5.2. Latin America Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million) 8.5.3. Latin America Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million) 8.6. Middle East And Africa 8.6.1. Middle East And Africa Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million) 8.6.2. Middle East And Africa Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million) 8.6.3. Middle East And Africa Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million) Chapter 9. Company Profile 9.1. Abbott Laboratories 9.1.1. Overview 9.1.2. Financials 9.1.3. Product Portfolio 9.1.4. Business Strategy 9.1.5. Recent Developments 9.2. AB Sciex Pte.Ltd. 9.2.1. Overview 9.2.2. Financials 9.2.3. Product Portfolio 9.2.4. Business Strategy 9.2.5. Recent Developments 9.3. Agilent Technologies 9.3.1. Overview 9.3.2. Financials 9.3.3. Product Portfolio 9.3.4. Business Strategy 9.3.5. Recent Developments 9.4. Biomedical Technologies. 9.4.1. Overview 9.4.2. Financials 9.4.3. Product Portfolio 9.4.4. Business Strategy 9.4.5. Recent Developments 9.5. bioMerieux SA 9.5.1. Overview 9.5.2. Financials 9.5.3. Product Portfolio 9.5.4. Business Strategy 9.5.5. Recent Developments 9.6. Bio-Rad Laboratories. 9.6.1. Overview 9.6.2. Financials 9.6.3. Product Portfolio 9.6.4. Business Strategy 9.6.5. Recent Developments 9.7. DiaSorin S.p.A. 9.7.1. Overview 9.7.2. Financials 9.7.3. Product Portfolio 9.7.4. Business Strategy 9.7.5. Recent Developments 9.8. Hoffmann-La Roche Ltd. 9.8.1. Overview 9.8.2. Financials 9.8.3. Product Portfolio 9.8.4. Business Strategy 9.8.5. Recent Developments 9.9. Quest Technology 9.9.1. Overview 9.9.2. Financials 9.9.3. Product Portfolio 9.9.4. Business Strategy 9.9.5. Recent Developments 9.10. Thermo Fisher Scientific, Inc. 9.10.1. Overview 9.10.2. Financials 9.10.3. Product Portfolio 9.10.4. Business Strategy 9.10.5. Recent Developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com